Pan-KRAS drugs for Pancreatic Ductal Adenocarcinoma
2 tracked Pan-KRAS drugs in the Pancreatic Ductal Adenocarcinoma race. The class explanation lives on the Pan-KRAS page; the full indication pipeline across every mechanism is on the Pancreatic Ductal Adenocarcinoma page.
2 preclinical / unstaged